Skip to playerSkip to main content
  • 5 months ago
During a House Energy Committee hearing before the Congressional Recess, Rep. Brett Guthrie (R-KY) asked Chief of the Organ Transplant Branch at the U.S. Department of Health and Human Services Dr. Raymond Lynch about guidelines for organ procurement.
Transcript
00:00Guthrie for his five minutes of questioning.
00:02Thanks, and thanks, Dr. Lynch.
00:03Thanks for being here, and thanks for your report.
00:05As I said, I'm opening, saying this is personal to me,
00:07and I want people to be organ donors,
00:09and I want people to have the ability to have a full life
00:13if they have the access to organs,
00:15but we want to make sure everything is right and done correctly.
00:19And one of the things I think you said,
00:21you weren't here at the beginning of this,
00:23but you didn't say, hey, I wasn't here,
00:24so it's not my responsibility at the time.
00:27Also, when we had our meeting,
00:31you didn't say, well, it's somebody else's issue, not mine.
00:33You said, HRSA has a role in this,
00:34and you just got started with Ms. Clark.
00:38So what does HRSA need to do different
00:41to make more confidence in the system?
00:44So I'd like to begin by expressing my apologies
00:47for the care that was delivered to your constituents,
00:50to the people of Kentucky.
00:51It's unacceptable, and it's not something
00:53that HRSA is going to let stand.
00:54This was the impetus for our corrective action plan
00:57to make sure that this did not continue in Kentucky
00:59and that other OPOs could learn by example.
01:02This is HRSA's responsibility.
01:05HRSA has this authority delegated by the secretary,
01:08and we intend to make sure that the OPTN
01:10and its contractors are able to fulfill this role.
01:14Okay, so thank you.
01:15So from your perspective, or from HRSA's perspective,
01:17what more needs to be done by others,
01:19including the hospitals, the OPOs, OPT,
01:22and all the different groups?
01:24What needs to be done differently?
01:25There's room for improvement by all parties,
01:28but the central figure here is the OPO.
01:31So nobody proceeds to organ procurement
01:33without an OPO's involvement.
01:36The OPO is the subject matter expert in this,
01:38and they are the ones who drive the process.
01:40They conduct the evaluation to identify
01:42and manage the donors,
01:44and they are responsible for the identification
01:47of transplantable organs that will be offered out for matching.
01:50So what do they need to do different
01:52to give more confidence to the system?
01:53So to, we need better policy within the OPTN
01:57to make sure that these lapses in care are preventable.
02:01We don't need to...
02:01So what updated policies, what would you...
02:03So right now there is, as specified in the regulation,
02:07there is attending to public health and patient safety.
02:11I think that we can speak definitively
02:13to improving DCD policy.
02:15This has been something that the OPTN board has discussed
02:18and other entities have discussed for years,
02:20but no action has been taken.
02:23So those who are listening,
02:25means it's circulatory.
02:27There's two types of...
02:28Could you explain the difference
02:29in brain debt and circulatory death?
02:32So the manner of organ donation and procurement
02:35that most people are familiar with is brain death.
02:38That is where somebody is legally deceased,
02:40their brain is not functioning,
02:42but their body is being maintained on ventilator
02:45and with medical support.
02:46And that group, which is a big group...
02:49Well, there's a bigger...
02:49Unfortunately, because of drug overdose,
02:51it's a bigger group of the second.
02:52But that group, we're really not questioning today
02:55what's being done with them, are we?
02:58HRSA has ongoing work to make sure
03:00that all forms of organ donation and procurement are safe.
03:03But brain debt is not...
03:05This is a different category.
03:06The case in Kentucky was donation
03:08after circulatory death or DCD.
03:10Historically, that was a less common pathway.
03:14In the United States right now,
03:16it's about 50% of the organ donors.
03:18In our case, it's because of, unfortunately,
03:20drug overdoses.
03:22So I'm going to answer a lot of my questions.
03:26Do you believe that...
03:27So policies and procedures need to be updated.
03:32And we need to follow them, obviously.
03:34So what specifically do you think
03:36in the Kentucky case would have...
03:37What was their OPO's responsibility
03:39in the Kentucky case,
03:40and where do you think it failed?
03:42So some of this could have been corrected locally.
03:44So under CMS regulations, which guide an OPO,
03:47they're required to have a quality department.
03:49Every OPO also has a medical director.
03:52Appropriate identification of the donors,
03:55appropriate re-evaluation of their neurologic status
03:58would have prevented many of these errors.
04:00Training and good hospital development,
04:02meaning building that collaborative relationship,
04:05and listening to the medical teams
04:06and the families would have prevented many of these.
04:09Okay.
04:11So will you commit to ensuring
04:12that there will be increased transparency from HRSA
04:15if and when it identifies other issues
04:17with organ procurement?
04:19And so those who are responsible for implementation,
04:22overseeing organ donations,
04:23procurement, and transplants
04:24can address these problems?
04:25Yes.
04:25Commit to working together?
04:26Well, I think it's important that as people are listening to this,
04:30there is a distinct difference in the two.
04:33I know we need to make sure everything works,
04:35but someone who's brain dead versus circulatory death,
04:38and we need to,
04:40and unfortunately the cases are rising
04:42with circulatory death,
04:43so we need to make sure we have the procedures in place
04:45to make sure someone is ready to donate
04:50before the process moves forward.
04:53But you have to prepare for it
04:55because you know they're going to die.
04:56That's the issue, isn't it,
04:58is that if there's circulatory death,
05:00you remove the,
05:01it's not brain dead,
05:02once you remove the treatment,
05:04they're passed.
05:05But circulatory death,
05:06when you remove the treatment,
05:07because they're going to die anyway,
05:09then it takes a little while.
05:11That's kind of the space we're worried about, right?
05:14There is ongoing work.
05:15There has been work for many years
05:16to try and get better at predicting
05:18who will pass and in what time frame.
05:20It remains inexact,
05:22but however you're planning on predicting that,
05:24you need accurate information,
05:25and that gets down to conducting
05:27a good neurologic exam
05:28and a good history
05:30on what is wrong with the patient.
05:32I yield back.
Be the first to comment
Add your comment

Recommended